SILVERARC CAPITAL MANAGEMENT, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001816307
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 64 positions · Total reported value $784.53M · Top-10 concentration 54.6% · Updated 2026-11-13
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
Turnover: 64.6% · 15 new · 20 cut · 18 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.8% · vs SPY -10.9% · Prev Value $855.33M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.7% · vs SPY -6.9% · Latest Value $784.53M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, SILVERARC CAPITAL MANAGEMENT, LLC disclosed 64 equity positions with a combined reported value of $784.53M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were KOD ($71.12M), CELC ($63.87M), COGT ($50.42M). By sector, the heaviest allocations are Health Care 95.8%, Financials 3.3%. Versus the prior quarter, allocation shifted toward Financials (+1.4pp), Other (+0.9pp) and away from Health Care (-2.3pp).
Versus the prior quarter, SILVERARC CAPITAL MANAGEMENT, LLC opened 15 new positions, trimmed 20 and fully exited 18, a turnover rate of 64.6% of positions. The portfolio's overlap with the prior quarter was 60% of names.
The largest new positions opened in Q3 2026 were CLDX ($12.01M), KRSP ($8.71M), DARE ($6.80M).
Of the 18 positions fully exited versus the prior quarter, the largest were VCYT ($18.68M), GH ($14.98M), TRVI ($12.65M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- CLDX CELLDEX THERAPEUTICS INC NEW · $12.01M
- KRSP RICE ACQUISITION CORP 3 · $8.71M
- DARE YARROW BIOSCIENCE INC · $6.80M
- ARCT ARCTURUS THERAPEUTICS HLDGS · $6.30M
- KNSA KINIKSA PHARMACEUTICALS INTL · $5.65M
- EVMN EVOMMUNE INC · $4.91M
- FTH FAETH THERAPEUTICS INC · $3.69M
- RACD RESEARCH ALLIANCE CORP IV · $3.50M
Fully Exited (vs previous quarter)
- VCYT VERACYTE INC · prev qtr: $18.68M
- GH GUARDANT HEALTH INC · prev qtr: $14.98M
- TRVI TREVI THERAPEUTICS INC · prev qtr: $12.65M
- MANE VERADERMICS INC · prev qtr: $11.68M
- XENE XENON PHARMACEUTICALS INC · prev qtr: $11.28M
- AVTX AVALO THERAPEUTICS INC · prev qtr: $9.25M
- WGS GENEDX HOLDINGS CORP · prev qtr: $8.39M
- ARTV ARTIVA BIOTHERAPEUTICS INC · prev qtr: $5.09M
Insider Transactions (Form 4)
Latest SILVERARC CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Silverarc Capital Management is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 67 US equity positions with a combined value of $855.33M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BOSTON, MA, United States
- SEC registration: 801-116845 (status: Approved), registered 2019-06-21
- Regulatory AUM (Form ADV): $1.61B as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 2 hedge funds
- Website: silverarccapital.com
Portfolio Structure
- 67 positions · $855.33M reported value (Q2 2026)
- Top 10 holdings = 47.1% of reported value
- Largest position: ASND (ASCENDIS PHARMA A/S) at 6.4%
- Average position size: $12.77M
Sector Tilt
- Health Care 98.1%
- Financials 1.9%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 19 new, 16 added, 28 reduced, 20 exited
- 4 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 20:37
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
750.17K | $71.12M | 9.06% | Add | |
| 2 |
|
803.19K | $63.87M | 8.14% | Add | |
| 3 |
|
1.57M | $50.42M | 6.43% | Add | |
| 4 |
|
1.15M | $46.67M | 5.95% | Reduce | |
| 5 |
|
2.09M | $45.01M | 5.74% | Add | |
| 6 |
|
3.75M | $37.01M | 4.72% | Add | |
| 7 |
|
152.18K | $34.67M | 4.42% | Reduce | |
| 8 |
|
348.32K | $33.17M | 4.23% | Add | |
| 9 |
|
112.79K | $25.48M | 3.25% | Add | |
| 10 |
|
624.05K | $21.08M | 2.69% | Add | |
| 11 |
|
236.58K | $20.83M | 2.65% | Reduce | |
| 12 |
|
247.92K | $20.65M | 2.63% | Reduce | |
| 13 |
|
1.33M | $19.50M | 2.49% | Add | |
| 14 |
|
175.70K | $17.40M | 2.22% | Add | |
| 15 |
|
5.95M | $14.82M | 1.89% | Add | |
| 16 |
|
151.15K | $13.46M | 1.72% | Add | |
| 17 |
|
345.95K | $13.17M | 1.68% | Reduce | |
| 18 |
|
1.21M | $12.83M | 1.64% | Add | |
| 19 |
|
300.43K | $12.17M | 1.55% | Add | |
| 20 |
|
370.70K | $12.01M | 1.53% | New | |
| 21 |
|
3.45M | $11.50M | 1.47% | Add | |
| 22 |
|
378.35K | $10.78M | 1.37% | Add | |
| 23 |
|
3.95M | $9.40M | 1.20% | Add | |
| 24 |
|
6.57M | $9.13M | 1.16% | Add | |
| 25 |
|
334.06K | $9.01M | 1.15% | Reduce | |
| 26 |
|
717.36K | $8.92M | 1.14% | Add | |
| 27 |
|
853.88K | $8.71M | 1.11% | New | |
| 28 |
|
3.59M | $8.54M | 1.09% | Add | |
| 29 |
|
1.52M | $7.84M | 1.00% | Add | |
| 30 |
|
125.08K | $7.12M | 0.91% | Reduce | |
| 31 |
|
301.92K | $6.80M | 0.87% | New | |
| 32 |
|
5.36M | $6.32M | 0.81% | Add | |
| 33 |
|
459.90K | $6.30M | 0.80% | New | |
| 34 |
|
525.00K | $6.26M | 0.80% | Add | |
| 35 |
|
19.75K | $5.75M | 0.73% | Reduce | |
| 36 |
|
75.70K | $5.65M | 0.72% | New | |
| 37 |
|
121.45K | $5.57M | 0.71% | Reduce | |
| 38 |
|
760.34K | $5.50M | 0.70% | Add | |
| 39 |
|
594.03K | $4.91M | 0.62% | New | |
| 40 |
|
247.42K | $4.65M | 0.59% | Reduce | |
| 41 |
|
443.11K | $4.43M | 0.56% | Reduce | |
| 42 |
|
404.73K | $4.38M | 0.56% | Add | |
| 43 |
|
124.10K | $3.69M | 0.47% | New | |
| 44 |
|
693.44K | $3.64M | 0.46% | Add | |
| 45 |
|
301.96K | $3.50M | 0.45% | New | |
| 46 |
|
216.62K | $3.47M | 0.44% | New | |
| 47 |
|
2.34M | $3.15M | 0.40% | New | |
| 48 |
|
47.31K | $3.10M | 0.40% | Reduce | |
| 49 |
|
2.14M | $2.46M | 0.31% | Hold | |
| 50 |
|
200.26K | $2.20M | 0.28% | New | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)
Historical Backtest (11 quarters)
Avg precision 60% · recall 60% · F1 60% · avg rank error 3.4 · Top-10 turnover 43%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2024-Q1 | 60% | 60% | 60% | MRUS · NUVL · MORF · PSTX · MGNX · RCKT · MDT · SNY · ORIC · CLDX | MRUS · SLDB · MORF · ORIC · MRSN · CLDX · RNAM · NUVL · PRAX · PSTX |
| 2024-Q2 | 70% | 70% | 70% | MRUS · SLDB · MORF · ORIC · MRSN · CLDX · RNAM · PSTX · AKRO · NUVL | MRUS · NUVL · RNAM · URGN · ERAS · MORF · AKRO · CLDX · ITCI · PSTX |
| 2024-Q3 | 60% | 60% | 60% | NUVL · MRUS · RNAM · ERAS · URGN · AKRO · MORF · ITCI · CLDX · PSTX | NUVL · MRUS · INSM · RNAM · ERAS · AKRO · VCYT · RYTM · COGT · ITCI |
| 2024-Q4 | 80% | 80% | 80% | NUVL · MRUS · INSM · RNAM · ERAS · AKRO · VCYT · RYTM · ITCI · COGT | NUVL · MRUS · INSM · VRNA · AKRO · VCYT · ERAS · PLRX · RNAM · RYTM |
| 2025-Q1 | 70% | 70% | 70% | NUVL · INSM · MRUS · VRNA · VCYT · AKRO · PLRX · ERAS · RYTM · RNAM | VRNA · MRUS · NUVL · AKRO · INSM · KALV · VCYT · RYTM · SNDX · URGN |
| 2025-Q2 | 70% | 70% | 70% | VRNA · MRUS · NUVL · AKRO · INSM · KALV · VCYT · RYTM · SNDX · URGN | MRUS · AKRO · VRNA · URGN · RYTM · INSM · KALV · NBIX · ETNB · ORIC |
| 2025-Q3 | 40% | 40% | 40% | MRUS · AKRO · VRNA · URGN · RYTM · INSM · KALV · NBIX · ETNB · ORIC | ABVX · RYTM · RNAM · NUVL · URGN · AKRO · INSM · DNTH · QURE · CGON |
| 2025-Q4 | 40% | 40% | 40% | ABVX · RNAM · RYTM · NUVL · URGN · AKRO · QURE · DNTH · INSM · UTHR | ABVX · COGT · URGN · CELC · NUVL · DNTH · KOD · PRAX · IMNM · GUTS |
| 2026-Q1 | 60% | 60% | 60% | ABVX · COGT · CELC · URGN · NUVL · DNTH · KOD · PRAX · IMNM · GUTS | KALV · DNTH · COGT · IMNM · KOD · NUVL · ABVX · GLUE · ERAS · ASND |
| 2026-Q2 | 40% | 40% | 40% | KALV · COGT · DNTH · IMNM · KOD · GLUE · NUVL · ASND · ABVX · ERAS | ASND · CELC · COGT · URGN · IMNM · DNTH · RYTM · ORKA · ELVN · IMVT |
| 2026-Q3 ★ | 70% | 70% | 70% | ASND · CELC · COGT · URGN · IMNM · RYTM · ORKA · DNTH · ELVN · IMVT | KOD · CELC · COGT · URGN · IMNM · SGMT · ASND · RYTM · BIIB · IMVT |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did SILVERARC CAPITAL MANAGEMENT, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, SILVERARC CAPITAL MANAGEMENT, LLC reported 64 equity positions worth $784.53M in aggregate; its largest disclosed positions were KOD ($71.12M), CELC ($63.87M), COGT ($50.42M).
How large is SILVERARC CAPITAL MANAGEMENT, LLC's portfolio?
SILVERARC CAPITAL MANAGEMENT, LLC reported $784.53M of long equity holdings across 64 positions as of 2026-Q3. Top-10 holdings account for 54.6% of reported value.
What is SILVERARC CAPITAL MANAGEMENT, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.